| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/LIV.13271 |
| P698 | PubMed publication ID | 27740738 |
| P50 | author | Phunchai Charatcharoenwitthaya | Q89704737 |
| Nonthalee Pausawasdi | Q92950778 | ||
| Tawesak Tanwandee | Q114366716 | ||
| P2093 | author name string | Wimolrak Bandidniyamanon | |
| Ananya Pongpaibul | |||
| Patommatat Bhanthumkomol | |||
| Uayporn Kaosombatwattana | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis | Q34061964 | ||
| The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis | Q34252404 | ||
| Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study | Q34317204 | ||
| Hemochromatosis and iron-overload screening in a racially diverse population. | Q34414406 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Q35893923 | ||
| Diabetes and prediabetes in patients with hepatitis B residing in North America. | Q36603659 | ||
| Effects of metabolic syndrome on fibrosis in chronic viral hepatitis | Q37046576 | ||
| Liver biopsy findings in chronic hepatitis B. | Q37462537 | ||
| Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications | Q37983300 | ||
| The role of angiotensin II in nonalcoholic steatohepatitis. | Q38009550 | ||
| Non-alcoholic fatty liver disease, obesity and the metabolic syndrome | Q38246472 | ||
| Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma | Q38506015 | ||
| Insulin resistance, steatosis and hepatitis C virus. | Q39240971 | ||
| Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations | Q42232725 | ||
| Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver | Q44749296 | ||
| Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis | Q45070082 | ||
| Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis | Q46931227 | ||
| Epidemiology of non-alcoholic fatty liver disease. | Q51566234 | ||
| P433 | issue | 4 | |
| P921 | main subject | steatohepatitis | Q2335423 |
| chronic hepatitis B | Q55779876 | ||
| P304 | page(s) | 542-551 | |
| P577 | publication date | 2016-10-14 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response | |
| P478 | volume | 37 |
| Q54760091 | Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? |
| Q59356467 | Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study |
| Q91914419 | Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B |
| Q41620908 | Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B. |
| Q64128957 | Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease |
Search more.